A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

NCT01291004 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicle Development
Ovarian Follicle
Follicle Count
Follicle Size
Oral Contraceptive

Interventions

DRUG: Desogestrel/ethinyl estradiol and ethinyl estradiol
DRUG: 28-day drospirenone oral contraceptive
DRUG: 28-day levonorgestrel oral contraceptive

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.